ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Pediatrics

Top Pediatrics Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARIA CELLARIO MD

Pediatrics

7,849

$466K

236
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 28%

$59
Average prescription price

Avg: $67

VIVIENNE TAYLOR M.D.

Pediatrics

6,862

$536K

411
202 are 65+

11%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 28%

$78
Average prescription price

Avg: $67

THOMAS PAYYAPILLI M.D

Pediatrics

5,147

$396K

127
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 28%

$77
Average prescription price

Avg: $67

BREDY PIERRE-LOUIS MD

Pediatrics

4,695

$202K

226
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 28%

$43
Average prescription price

Avg: $67

NALINI PARIKH M.D.

Pediatrics

4,638

$231K

216
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 28%

$50
Average prescription price

Avg: $67

MARTIN ANIM MD

Pediatrics

4,426

$220K

127
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 28%

$50
Average prescription price

Avg: $67

STANLEY COHEN MD, F.A.A.P.

Pediatrics

4,423

$427K

88
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 28%

$97
Average prescription price

Avg: $67

OFELIA MARTINEZ MD

Pediatrics

3,835

$215K

98
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $67

PHILIP WILKEN MD

Pediatrics

3,808

$342K

90
13 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 28%

$90
Average prescription price

Avg: $67

MARK MCSWAIN M.D.

Pediatrics

3,270

$193K

114
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 28%

$59
Average prescription price

Avg: $67

ROB SHELLY MD

Pediatrics

3,219

$179K

232
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $67

MUHAMMAD HAQUE

Pediatrics

3,126

$183K

261
196 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 28%

$59
Average prescription price

Avg: $67

JUNG CHOU MD

Pediatrics

2,986

$269K

59
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 28%

$90
Average prescription price

Avg: $67

MINERVA BRUNO MD

Pediatrics

2,789

$140K

220
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 28%

$50
Average prescription price

Avg: $67

GEORGE COOK MD

Pediatrics

2,626

$178K

118
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $67

TOBY TAYLOR MD

Pediatrics

2,527

$179K

133
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 28%

$71
Average prescription price

Avg: $67

AFSHIN SHAHKOOHI MD

Pediatrics

2,464

$164K

135
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 28%

$67
Average prescription price

Avg: $67

DAVID CARMILI M.D.

Pediatrics

2,285

$156K

137
87 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $67

CAROLINE GOMEZ-DICESARE M.D.

Pediatrics

2,276

$164K

180
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 28%

$72
Average prescription price

Avg: $67

DANIEL UMALI M.D.

Pediatrics

2,245

$189K

56
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 28%

$84
Average prescription price

Avg: $67

KAREN NEAD M.D.

Pediatrics

1,856

$110K

109
47 are 65+

17%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 28%

$59
Average prescription price

Avg: $67

UNG KYU LIM MD

Pediatrics

1,847

$144K

73
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 28%

$78
Average prescription price

Avg: $67

JOSEPH GRANEY M.D.

Pediatrics

1,813

$145K

129
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 28%

$80
Average prescription price

Avg: $67

ANDRES PEREIRA M.D.

Pediatrics

1,548

$95.2K

64
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

23%
patients receiving schedule three controlled substances

Avg: 3%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 28%

$61
Average prescription price

Avg: $67

DAVID BREEN MD

Pediatrics

1,432

$80.7K

98
35 are 65+

16%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank